Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000919574-24-007004
Filing Date
2024-12-04
Accepted
2024-12-04 16:32:39
Documents
1

Document Format Files

Seq Description Document Type Size
1 d11538049_13g.htm SC 13G 106551
  Complete submission text file 0000919574-24-007004.txt   108267
Mailing Address 540 MADISON AVENUE 7TH FLOOR NEW YORK NY 10022
Business Address 540 MADISON AVENUE 7TH FLOOR NEW YORK NY 10022 2127025204
SUVRETTA CAPITAL MANAGEMENT, LLC (Filed by) CIK: 0001569064 (see all company filings)

EIN.: 453704500 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 18 CAMPUS BLVD. SUITE 100 NEWTOWN SQUARE PA 19073-3269
Business Address 18 CAMPUS BLVD. SUITE 100 NEWTOWN SQUARE PA 19073-3269 240-780-6356
ArriVent BioPharma, Inc. (Subject) CIK: 0001868279 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-94331 | Film No.: 241526622
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)